Telo Genomics initiates multiple myeloma minimal residual disease trial in collaboration with the University of Athens: Toronto, Ontario Saturday, December 20, 2025, 15:00 Hrs [IS ...

European Commission grants orphan drug designation to Memo Therapeutics’ potravitug to treat BKPyV infection in kidney transplant recipients: Zurich, Switzerland Saturday, Decem ...